ANI Pharma (ANIP) Tops Q1 EPS by 1c

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $0.57, $0.01 better than the analyst estimate of $0.56. Revenue for the quarter came in at $18.8 million versus the consensus estimate of $19.9 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
• JD.com earnings preview: stronger profit expected, macro headwinds in focus
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance